Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025. GUILFORD, Conn. / Dec 17, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared... Read More

Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop® system for imaging diverse patient groups in emergency departments and neuro ICUs. GUILFORD, Conn. / Dec 05, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has... Read More

Two new executive roles position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting, laying the foundation for significant growth in 2025 and beyond. GUILFORD, Conn. / Dec 03, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology... Read More

Intersocietal Accreditation Commission (IAC)’s release of new standards accepting ultra-low-field MRI technology enables accredited facilities to qualify for reimbursement from the US Centers for Medicare & Medicaid Services (CMS). GUILFORD, Conn. / Nov 21, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the... Read More

The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing relevance of portable, ultra-low-field MR brain imaging. GUILFORD, Conn. / Nov 19, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the... Read More

GUILFORD, Conn. / Nov 13, 2024 / Business Wire / Hyperfine, Inc . (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming BTIG Digital Health Forum on Monday, November 25, 2024. Management will also participate in the Mizuho Healthcare... Read More

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update. “The Hyperfine team delivered yet another strong quarter of financial... Read More

CE approval of the latest generation Swoop ® system software is a significant milestone in Hyperfine’s international strategy, allowing broader European commercial expansion. GUILFORD, Conn. / Nov 07, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain... Read More

Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities (ARIA). MADRID / Oct 31, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has... Read More

GUILFORD, Conn. / Oct 24, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the third quarter 2024 on Tuesday, November 12, 2024. Management will host a corresponding conference call at... Read More

The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury (ABI) GUILFORD, Conn. / Oct 01, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company... Read More

The Swoop® Portable MR Imaging® system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke care PARIS / Sep 23, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of... Read More

GUILFORD, Conn. / Sep 11, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South... Read More

GUILFORD, Conn. / Aug 28, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming H.C. Wainwright 26th Annual Global Investment Conference. Members of management are scheduled to present on Monday,... Read More

Reports $3.6M in Q2 2024 Revenue; 50% Gross Margin Raises FY 2024 Revenue Guidance to $13-16M GUILFORD, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced second quarter 2024 financial results and provided a... Read More

Two poster presentations at AAIC provide early evidence of the value of ultra-low-field Swoop® system MR brain images in ARIA-E detection and morphography evaluation in patients with Alzheimer's disease PHILADELPHIA / Jul 30, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain... Read More

The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. GUILFORD, Conn. / Jul 17, 2024 / Business Wire / Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced the clearance of the... Read More

The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. GUILFORD, Conn. / Jul 15, 2024 / Business Wire / Hyperfine (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance... Read More

GUILFORD, Conn. / Jul 11, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Management will host a corresponding conference call at... Read More

New distribution partnerships further global expansion plans for the Swoop system, growing the reach of Hyperfine to a total of twelve European countries GUILFORD, Conn. / Jul 10, 2024 / Business Wire / Hyperfine (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop ® system—today announced it... Read More

Portable ultra-low-field MR brain imaging provides affordable and accessible technology that may help physicians monitor ARIA and Alzheimer's disease progression in diverse professional care settings. GUILFORD, Conn. / Jun 25, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain... Read More

Led by Edmond Knopp, MD, VP of Medical Affairs Welcoming three KOLs to discuss clinical developments in ultra-low-field (ULF) MR imaging GUILFORD, Conn. / Jun 03, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced it will host an... Read More

Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market GUILFORD, Conn. / May 28, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced it has... Read More

GUILFORD, Conn. / May 22, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference, in New York, NY. Members of management are scheduled to present on Thursday, June... Read More

The 2024 ASNR Annual Meeting had a strong focus on Alzheimer’s disease care and growing excitement about ultra-low-field MRI LAS VEGAS / May 22, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop ® system—today announced that the company participated in... Read More

GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update. “We have kicked off 2024 strong. I am pleased with our commercial progress shown by... Read More

Distributors appointed in France, the United Kingdom, and Italy Industry veteran Enrico Barini joins as International Business Development Director GUILFORD, Conn. / May 10, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced it has... Read More

GUILFORD, Conn. / Apr 29, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the first quarter 2024 on Monday, May 13, 2024. Management will host a corresponding conference call at 1:30... Read More

Data on the company’s portable MR imaging system show it can acquire brain images at the point of care that may assist physicians with screening and monitoring for Alzheimer’s and multiple sclerosis biomarkers GUILFORD, Conn. / Apr 23, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR)... Read More

Study will assess the clinical utility and workflow benefits of physicians using images acquired by the Swoop® Portable MR Imaging® system to identify ARIA events in Alzheimer’s patients treated with amyloid-targeting therapy GUILFORD, Conn. / Apr 17, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking... Read More

GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2023 financial results and provided a business update. “I am pleased with our strong growth in 2023. We continued to drive... Read More

The Princess Royal was introduced to the first FDA-cleared portable MR brain imaging system being used to test the disparities in MR access in low- and medium-resource countries GUILFORD, Conn. / Mar 12, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the developer of the first FDA-cleared portable magnetic resonance... Read More

GUILFORD, Conn. / Mar 07, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 21, 2024. Management will host a corresponding... Read More

GUILFORD, Conn. / Feb 28, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced plans to present at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference, taking place virtually. Members of management... Read More

The collaboration kicked off at the 2024 All-Star game in Indianapolis Athletic Heart will use the Swoop® Portable MR Imaging® system to provide brain imaging GUILFORD, Conn. & ORLANDO, Fla. / Feb 21, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain... Read More

Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field MR brain imaging to aid physicians in the diagnosis of acute ischemic stroke GUILFORD, Conn. / Feb 01, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop... Read More

The latest software, the eighth generation of Swoop® system software, has obtained CE and UKCA approval GUILFORD, Conn. / Jan 09, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain... Read More

Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field brain imaging to assist in improving brain health GUILFORD, Conn. / Nov 20, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first... Read More

GUILFORD, Conn. / Nov 16, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced plans to present at the upcoming Piper Sandler 35th Annual Healthcare Conference, in New York. Members of management are scheduled to... Read More

GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced third quarter 2023 financial results and provided a business update. “We remain focused on our three strategic pillars of innovation,... Read More

Results from study presented at the 2023 Asia-Pacific Extracorporeal Life Support Organization (APELSO) meeting GUILFORD, Conn. / Nov 02, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable,... Read More

GUILFORD, Conn. / Oct 19, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023. Management will host a corresponding conference call at... Read More

New vice presidents of medical affairs and scientific affairs will support brain health innovation GUILFORD, Conn. / Oct 10, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced the promotions of neuroradiologists,... Read More

Advanced artificial intelligence (AI) algorithms are now integrated across all Swoop® ultra-low-field brain imaging system sequences GUILFORD, Conn. / Oct 09, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced FDA clearance of... Read More

GUILFORD, Conn. / Sep 07, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually. Members of management are scheduled to present on Thursday, September 21,... Read More

GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced second quarter 2023 financial results and provided a business update. “We made solid progress at Hyperfine in the second quarter of 2023 and delivered record revenue of over $3.3 million.... Read More

Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus management GUILFORD, Conn. / Aug 09, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced completed enrollment for the multi-site observational study, HOPE... Read More

GUILFORD, Conn. / Jul 24, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the second quarter 2023 on Monday, August 14, 2023. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live... Read More

GUILFORD, Conn. / Jul 18, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer. Dr. Teisseyre will oversee product design and development, clinical science, operations, cybersecurity, and... Read More

In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives GUILFORD, Conn. / Jul 11, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international,... Read More

Program seeks to increase neuroimaging clinical research and knowledge transfer between high-income and low- and medium-income countries TORONTO / Jun 08, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, is proud to be the first magnetic resonance imaging technology... Read More

Clinical research, supported by funding from the Bill & Melinda Gates Foundation, has the potential to make a profound impact on global maternal and childhood health GUILFORD, Conn. / May 18, 2023 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced an... Read More

GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced first quarter 2023 financial results and provided a business update. “We had strong growth at Hyperfine in the first quarter of 2023 and delivered record revenue of $2.6 million. We remained... Read More

GUILFORD, Conn., April 20, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A... Read More

GUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™ today announced fourth quarter and full year 2022 financial results and provided a business update. “We made measurable progress at Hyperfine over the past year. We delivered $6.8 million in revenue in 2022, received... Read More

GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system, today announced that it will report financial results for the fourth quarter and full year 2022 on Tuesday, March 21, 2023. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m.... Read More

GUILFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable MRI system, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the latest update of its Swoop® system software. This updated software, which significantly improves diffusion-weighted imaging (DWI),... Read More

GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, today announced CE Marking for the product. While the company will maintain its commercial focus in the U.S. in 2023, CE Marking opens the door for potential future commercial expansion into the European Economic Area... Read More

GUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. , the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the brain, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software. The most recently cleared Swoop ® software... Read More

GUILFORD, Conn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, today announced the presentation of new data regarding the use of the Swoop ® system in stroke patient follow-up at the 2023 International Stroke Conference (ISC) in Dallas, Texas. In this study, conducted between... Read More

GUILFORD, Conn., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that Brett Hale will join Hyperfine, Inc. on February 13, 2023 and will serve as Chief Administrative Officer & Chief Financial Officer (CFO). Alok Gupta, who currently serves as CFO, will step down on or about... Read More

GUILFORD, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. , creator of the Swoop® Point-of-Care MRI System™ for imaging of the brain, today announced the acceptance of twelve abstracts related to the Swoop® system to be presented at the prestigious International Society for Magnetic Resonance in Medicine (ISMRM) and International Society of MR Radiologist and Technologists (ISMRT) annual meeting. The annual ISMRM... Read More